| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 12/11/2003 | WO2003084980A3 Peptide amphiphile solutions and self assembled peptide nanofiber networks |
| 12/11/2003 | WO2003080666A3 An adipocyte insulin and a method of treating diabetes |
| 12/11/2003 | WO2003074568A9 Individualized anti-cancer antibodies |
| 12/11/2003 | WO2003074562A3 Vanilloid receptor (trpv) fusion proteins |
| 12/11/2003 | WO2003070265A3 Hedgehog-related prophylaxis, therapy and diagnosis of gi tract carcinogenesis |
| 12/11/2003 | WO2003066098A3 Snares and methods of controlling cytokinesis |
| 12/11/2003 | WO2003066079A3 Novel epitopes for celiac disease and autoimmune diseases, methods for detecting those and novel non-antigenic food compounds |
| 12/11/2003 | WO2003065977A3 Modified antigen-presenting cells |
| 12/11/2003 | WO2003064463A3 Pluripotency determining factors and uses thereof |
| 12/11/2003 | WO2003057847A3 METHODS AND MATERIALS FOR MODULATING ENaC-BETA |
| 12/11/2003 | WO2003057666A3 Inhibitors of dipeptidyl peptidase iv |
| 12/11/2003 | WO2003057235A3 Modification of feeding behavior |
| 12/11/2003 | WO2003053347A3 Galliumcomplexes of 3-hydroxy-4-pyrones to treat mycobacterial infections |
| 12/11/2003 | WO2003052110A3 Nucleic acid nematicides |
| 12/11/2003 | WO2003051180A3 METHODS AND COMPOSITIONS FOR TREATING HEMATOLOGICAL DISORDERS USING 252, 304, 19870, 14717, 9941, 19310 and 17832 |
| 12/11/2003 | WO2003050141A3 Calpain activators |
| 12/11/2003 | WO2003048206A3 Growth hormone agonist peptides and their uses |
| 12/11/2003 | WO2003044053A3 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 12/11/2003 | WO2003040365A3 Pna-conjugate or pna-conjugate mixture for treating diseases related to the human papillomavirus |
| 12/11/2003 | WO2003038063A3 Human secreted proteins |
| 12/11/2003 | WO2003038037A3 Glycogen synthase kinase function in endothelial cells |
| 12/11/2003 | WO2003037266A3 Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity |
| 12/11/2003 | WO2003037172A9 Endothelial-cell binding peptides for diagnosis and therapy |
| 12/11/2003 | WO2003037166A3 Devices and methods for the restoration of a spinal disc |
| 12/11/2003 | WO2003034996A3 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment |
| 12/11/2003 | WO2003033663A8 Rankl mimics and uses thereof |
| 12/11/2003 | WO2003030928A3 Antitumor preparation |
| 12/11/2003 | WO2003029486A3 Single nucleotide polymorphisms predicting cardiovascular disease |
| 12/11/2003 | WO2003029422A3 Noonan syndrome gene |
| 12/11/2003 | WO2003029407A3 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof |
| 12/11/2003 | WO2003029292A3 Gene regulatory peptides |
| 12/11/2003 | WO2003026580A3 Interactive therapeutic enclosures |
| 12/11/2003 | WO2003026579A3 Combination therapies for immune mediated diseases |
| 12/11/2003 | WO2003025225A3 Pthr1 gene polymorphisms |
| 12/11/2003 | WO2003024387A3 Method and pharmaceutical composition for treating inflammation |
| 12/11/2003 | WO2003022883A3 Use of proteins for the production of a medicament for stimulating the innate non specific immune system |
| 12/11/2003 | WO2003017940A3 Pulsatile release compositions and methods for enhanced gastrointestinal drug absorption |
| 12/11/2003 | WO2003013569A3 Use of thrombin-derived peptides for the therapy of chronic dermal ulcers |
| 12/11/2003 | WO2003011895A8 Compositions and methods for modulation of immune responses |
| 12/11/2003 | WO2003009740A3 Methods for treating or preventing sclerotic disorders using cd2-binding agents |
| 12/11/2003 | WO2003008549A3 Antisense modulation of glioma-associated oncogene-3 expression |
| 12/11/2003 | WO2003002745A3 The cage gene of actinobacillus actinomycetemcomitans, the protein it encodes and uses thereof |
| 12/11/2003 | WO2003000727A3 Atopy |
| 12/11/2003 | WO2003000719A3 Multiple antigenic peptide displaying multiple copies of an epitope of plaque-forming polypeptide and methods of using same |
| 12/11/2003 | WO2003000179A3 Chemically-modified progenipoietin conjugates |
| 12/11/2003 | WO2002100885A3 A penta- or tetrapeptide binding to somatostatin receptors and the use of the same |
| 12/11/2003 | WO2002098914A3 Mutants of igf binding proteins and methods of production of antagonists thereof |
| 12/11/2003 | WO2002092785A3 Composition and methods relating to ovarian specific genes and proteins |
| 12/11/2003 | WO2002092018A3 Methods for inducing sustained immune response |
| 12/11/2003 | WO2002083841A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 12/11/2003 | WO2002083067A3 Prodrugs via acylation with cinnamate |
| 12/11/2003 | WO2002081506A8 Process for producing trunkamide a compounds |
| 12/11/2003 | WO2002079407A3 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof |
| 12/11/2003 | WO2002077034A3 Modified granulocyte colony stimulating factor (g-csf) with reduced immunogenicity |
| 12/11/2003 | WO2002067986A3 Symbiotic regenerative agent |
| 12/11/2003 | WO2002065943A3 Ocular tear growth factor-like protein |
| 12/11/2003 | WO2002064788A3 Compositions and methods relating to lung specific genes and proteins |
| 12/11/2003 | WO2002048191A3 Inhibitory agents derived from specific growth factors |
| 12/11/2003 | WO2002046212A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 12/11/2003 | WO2002043758A3 Uses of mammalian genes and related reagents |
| 12/11/2003 | WO2002040657A3 47169 and 33935, novel glycosyl transferases and uses therefor |
| 12/11/2003 | WO1999024553A3 X-ray crystal comprising hiv-1 gp120 |
| 12/11/2003 | US20030229925 Recombinant lactoferrins, methods of production from plants and uses thereof |
| 12/11/2003 | US20030229908 Generating isogenic progenitor cells using nuclear transfer into enucleated oocytes for use as gene therapeutic tool in the treatment of cancer, muscular, nervous system, autoimmune and bone disorders; enzyme inhibitors; antiapoptosis |
| 12/11/2003 | US20030229907 Transgenic non-human mammals with progressive neurologic disease |
| 12/11/2003 | US20030229905 Generation of xenogeneic antibodies |
| 12/11/2003 | US20030229904 Comprises polypeptide for diagnosis, treatment and prevention of tumors |
| 12/11/2003 | US20030229217 Comprises gamma-amino butyric acid (GABA) receptor subunits for treatment of obesity, vision defects, high blood pressure, depression and sexual disorders |
| 12/11/2003 | US20030229216 Constitutively activated human G protein coupled receptors |
| 12/11/2003 | US20030229211 Isolating an endotoxin binding protein from horseshoe crab for treatment of septic shock |
| 12/11/2003 | US20030229209 Comprises mitogen-activated protein (MAP) kinase polypeptide for treating muscular, diabetic and nervous system disorders |
| 12/11/2003 | US20030229208 Humanized immunoglobulins |
| 12/11/2003 | US20030229207 Comprises immunoglobulin protein for preventing and treating transplant rejection, multiple sclerosis, autoimmune and graft-versus-host disease |
| 12/11/2003 | US20030229205 Silver halide emulsion for improving photographic products such as photographic paper or cellulose films |
| 12/11/2003 | US20030229204 PCG-1, a novel brown fat PPARgamma coactivator |
| 12/11/2003 | US20030229203 Chemokine variants and methods of use |
| 12/11/2003 | US20030229202 Comprises fusion protein for intracelluar delivery of compounds of interest into cells; drug delivery |
| 12/11/2003 | US20030229200 Useful in treating or preventing obesity |
| 12/11/2003 | US20030229199 Modulator comprising cyclic peptide for use in treatment of cancer, gastrointestinal, inflammatory and nervous system disordrers |
| 12/11/2003 | US20030229144 Anti-epileptogenic agents |
| 12/11/2003 | US20030229120 Zinc binding ligand; sustained release of insulin |
| 12/11/2003 | US20030229064 Method of treating cancer using dithiocarbamate derivatives |
| 12/11/2003 | US20030229053 Compounds and methods for the treatment or prevention of flavivirus infections |
| 12/11/2003 | US20030229046 Genetic engineering; polynucleotides; translation of codon of human cytomegalo virus |
| 12/11/2003 | US20030229045 CFTR gene regulator |
| 12/11/2003 | US20030229044 Use of statins and other immunomodulatory agents in the treatment of autoimmune disease |
| 12/11/2003 | US20030229043 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 12/11/2003 | US20030229041 Administering steroid compound |
| 12/11/2003 | US20030229040 Anticancer agents; complexing with lipids |
| 12/11/2003 | US20030229038 Lunasin peptides |
| 12/11/2003 | US20030229034 Drug delivery; nucleic acids; complexing |
| 12/11/2003 | US20030229024 Methods and compounds for inhibiting beta-amyloid peptide release and/or its synthesis |
| 12/11/2003 | US20030229023 Anticancer agents; skin disorders; antiinflamamtory agents; antiarthritic agents |
| 12/11/2003 | US20030229022 Sustained release; angigenesis inhibitors |
| 12/11/2003 | US20030229021 Antiallergens |
| 12/11/2003 | US20030229020 Vaccine; induce immunology response; administering monoclonal antibodies |
| 12/11/2003 | US20030229019 Compounds that selectively bind to expanded polyglutamine repeat domains and methods of use thereof |
| 12/11/2003 | US20030229018 Dimeric TF antagonist |
| 12/11/2003 | US20030229017 Solid phase method for synthesis peptide-spacer-lipid conjugates, conjugates synthesized thereby and targeted liposomes containing the same |
| 12/11/2003 | US20030229016 Genetic engineering; binding to antibody |